The Pharmacology Center

Filter Your Results

 

News

 

Dabigatran Shown to Reduce Major Cardiovascular Complications in Patients With Myocardial Injury After Noncardiac Surgery

March 11, 2018 -- Treatment with the anticoagulant drug dabigatran significantly reduced the risk of death, heart attack, stroke, and other heart or blood vessel complications…

SECURE-PCI Studies Benefit of Administering Statins at Time of PCI

March 11, 2018 -- The SECURE-PCI randomized clinical trial evaluated the effect of administering a loading dose of atorvastatin before planned percutaneous coronary interventi…

Alirocumab PCSK9 Inhibitor Studied in ODYSSEY Outcomes Trial of ACS Patients

March 10, 2018 -- Findings from the ODYSSEY Outcomes trial investigating cardiovascular outcomes with alirocumab after acute coronary syndrome were presented by Philippe Gabri…

REAC-TAVI Evaluates Ticagrelor to Suppress Platelet Reactivity After TAVR

March 5, 2018 -- Ticagrelor is more effective than clopidogrel at suppressing high platelet reactivity after transcatheter aortic valve replacement (TAVR) in patients with sev…

Abbott Vascular's XIENCE 28 GLOBAL Trial Enrolls First Patient in Europe

February 12, 2018 -- Abbott Vascular announced the first patient has been enrolled in XIENCE 28 GLOBAL, a clinical trial evaluating whether patients at high risk of bleeding c…

FDA Seeks to Strengthen Public Warnings and Recall Notifications; CDRH Outlines Strategic Priorities

January 18, 2018 -- US Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, issued a statement on the agency's new policy steps for strengthening public war…

One-Year Outcomes From PRAGUE-18 Trial Compare Prasugrel and Ticagrelor

January 22, 2018 -- One-year outcomes from the PRAGUE-18 trial, a comparison of prasugrel and ticagrelor for the treatment of acute myocardial infarction (MI), were published …

Findings Published From PRESTIGE Registry Evaluating High Platelet Reactivity

December 21, 2017 -- Results from the PRESTIGE registry were published by Thea C. Godschalk, MSc, et al in Journal of the American College of Cardiology (JACC): Cardiovascular…

 

advertisement

2018 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.